1
Conclusions: The combined form of membranous nephropathy and mesangioproliferative IgA nephropathy was uncommon.
2
Prednisolone and immunosuppressive agent were most effective in these patients with membranous nephropathy.
3
This knowledge is important for the rational design of new therapies for membranous nephropathy.
4
Background: Idiopathic membranous nephropathy remains the leading cause of nephrotic syndrome in Caucasian adults.
5
However, it is unknown whether smoking similarly increases the risk for progression of membranous nephropathy.
6
In the middle-aged group, the two most common pathological patterns were IgAN and membranous nephropathy.
7
Clinical cure was effected in a patient with biopsy-proven membranous nephropathy associated with spinal schwannoma.
8
Autoantibodies-mediating primary membranous nephropathy are predominantly of IgG4 subclass, which cannot activate the classical pathway.
9
The risk of venous thromboembolic events is thought to be highest in patients with membranous nephropathy.
10
Stage I and II based on electron-microscopy, were mainly observed in the patients, with membranous nephropathy.
11
Nephrotic syndrome was the most common clinic manifestation and membranous nephropathy was the most common pathology.
12
Careful workup in patients with membranous nephropathy should include not only malignant but also benign tumors.
13
Background: Lymphocytes are believed to play a role in the induction and perpetuation of membranous nephropathy.
14
Further studies are needed to discover mechanisms responsible for this high risk in patients with membranous nephropathy.
15
Background: Prostate cancer is the second most common solid tumor leading to membranous nephropathy (MN).
16
Conclusions: The course of HBV-related membranous nephropathy in adults in areas where HBV is endemic is not benign.
